Cargando…

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy

Between 2016 and 2021, we retrospectively identified 42 patients receiving ≥1 dose of dalbavancin for osteomyelitis, skin and soft-tissue infection, endocarditis or bacteremia, or septic arthritis. Median antibiotic duration prior to dalbavancin administration was 7 days. Within 90 days, 93% achieve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuan, Jessica J., Kayani, Jehanzeb, Fisher, Ann, Kotansky, Brian, Dembry, Louise-Marie, Datta, Rupak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726471/ https://www.ncbi.nlm.nih.gov/pubmed/36483361 http://dx.doi.org/10.1017/ash.2022.229

Ejemplares similares

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy
por: Tuan, Jessica, et al.
Publicado: (2021)

162. Assessment of Guideline-Concordant Testing for Legionella pneumophila and Streptococcus pneumoniae in Community-Acquired Pneumonia
por: Malik, Waleed, et al.
Publicado: (2022)

Patient outcomes following home-based outpatient parenteral antimicrobial therapy and facility-based outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis
por: Hasegawa, Shinya, et al.
Publicado: (2023)

Comparison of traditional instruction versus nontraditional learning to improve trainee knowledge of urine culture practices in catheterized patients
por: Gao, Catherine A., et al.
Publicado: (2022)

Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program
por: Britt, Rachel S., et al.
Publicado: (2023)

Rate of broad-spectrum antibiotic overuse in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Brenon, Jessa R., et al.
Publicado: (2021)

234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

Outcomes among patients with Staphylococcus aureus bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center
por: Theodore, Deborah A., et al.
Publicado: (2022)

Identification of priority targets for intervention in outpatient antimicrobial stewardship
por: Arensman Hannan, Kellie N., et al.
Publicado: (2022)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
por: Bork, Jacqueline T., et al.
Publicado: (2019)

Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults
por: Brzozowski, Kaylen, et al.
Publicado: (2020)

1932. Healthcare Utilization in Older vs. Younger Adults on Outpatient Parenteral Antimicrobial Therapy According to Discharge Location
por: Datta, Rupak, et al.
Publicado: (2018)

Decreased antimicrobial prescribing rate following academic detailing of resident physicians in outpatient clinic
por: Andrews, Shannon L., et al.
Publicado: (2023)

Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs)
por: Winders, Hana R., et al.
Publicado: (2022)

County-level spatiotemporal distribution of fluoroquinolone-resistant Enterobacteriaceae in outpatient settings of the Veterans’ Health Administration, 2000–2017
por: Smith, Matthew W., et al.
Publicado: (2023)

Is the number of prescriptions an appropriate metric for outpatient antimicrobial consumption? A comparison between the prescription counts and days supplied
por: Kakiuchi, Satoshi, et al.
Publicado: (2023)

754. Evaluation of Standardized Dalbavancin Use to Facilitate Early Hospital Discharge for Patients Inappropriate for Outpatient Parenteral Antibiotic Therapy
por: Shihadeh, Katherine C, et al.
Publicado: (2019)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

248. Antimicrobial Therapy for Suspected Urinary Tract Infection in Advanced Cancer Patients Transitioning to Comfort Measures
por: Wang, Tianyun, et al.
Publicado: (2018)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
por: Lee, Seohyuk, et al.
Publicado: (2022)

Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines
por: Ng, Nicole, et al.
Publicado: (2021)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R., et al.
Publicado: (2017)

Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians
por: Carter, Bernie, et al.
Publicado: (2021)

Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
por: Mahoney, Monica V., et al.
Publicado: (2021)

Improving antibiotic utilization through an outpatient stewardship initiative
por: Hiryak, Kayla M., et al.
Publicado: (2023)

Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration
por: Britt, Rachel S, et al.
Publicado: (2019)

1832. Concordance in End-of-Life Antimicrobial Prescribing Practices among Medicine Subspecialists
por: Datta, Rupak, et al.
Publicado: (2018)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

Impact of antimicrobial use in dogs on antimicrobial resistance and shared flora with human owners
por: Beaulac, Kirthana, et al.
Publicado: (2023)

Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis
por: Lind, Jennifer N., et al.
Publicado: (2021)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

1015. Real World Use of Dalbavancin and Oritavancin for Optimized Outpatient Antimicrobial Therapy in Patients Inappropriate for Standard Therapy
por: Weichman, Brittani, et al.
Publicado: (2022)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9s712i23fltsuraro8tqi3ttcj